Related references
Note: Only part of the references are listed.Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion
Xuanmao Jiao et al.
CANCER RESEARCH (2018)
TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer
Ke Gong et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition
Jeffrey S. Damrauer et al.
MOLECULAR CANCER RESEARCH (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
Jhajaira M. Araujo et al.
SCIENTIFIC REPORTS (2018)
Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer
Nathaniel W. Mabe et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment
Amanda L. Hudson et al.
FRONTIERS IN ONCOLOGY (2018)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Dynamics of the cell-mediated immune response to tumour growth
Alvaro G. Lopez et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2017)
C-C Chemokine Ligand-5 is critical for facilitating macrophage infiltration in the early phase of liver ischemia/reperfusion injury
Chiou-Mei Lee et al.
SCIENTIFIC REPORTS (2017)
Tumor macrophages are pivotal constructors of tumor collagenous matrix
Ran Afik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata et al.
NATURE MEDICINE (2016)
Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways
Flavia V. Santa-Cecilia et al.
NEUROTOXICITY RESEARCH (2016)
Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells
Carolina V. Alexander-Savino et al.
ONCOTARGET (2016)
Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment
Fabian Flores-Borja et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
The Inflammatory Chemokine CCL5 and Cancer Progression
Donatella Aldinucci et al.
MEDIATORS OF INFLAMMATION (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy
James V. Alvarez et al.
CANCER CELL (2013)
CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells
Debbie C. Strachan et al.
ONCOIMMUNOLOGY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
Marco Velasco-Velazquez et al.
CANCER RESEARCH (2012)
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu et al.
JOURNAL OF CELL BIOLOGY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Mechanisms of pulmonary fibrosis: role of activated myofibroblasts and NADPH oxidase
Victor J. Thannickal
FIBROGENESIS & TISSUE REPAIR (2012)
VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors
Xin Lu et al.
CANCER CELL (2011)
ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
Maria Soledad Sosa et al.
CLINICAL CANCER RESEARCH (2011)
Basal-like molecular subtype and HER4 up-regulation and response to neoadjuvant chemotherapy in breast cancer
Elmar Stickeler et al.
ONCOLOGY REPORTS (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Distant metastases do not metastasize
Dieter Hoelzel et al.
CANCER AND METASTASIS REVIEWS (2010)
The Canonical NF-κB Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion
Manran Liu et al.
CANCER RESEARCH (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Nuclear Factor-κB Enhances ErbB2-Induced Mammary Tumorigenesis and Neoangiogenesis in Vivo
Manran Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
Eric Campeau et al.
PLOS ONE (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Environment-mediated drug resistance: a major contributor to minimal residual disease
Mark B. Meads et al.
NATURE REVIEWS CANCER (2009)
Parallel progression of primary tumours and metastases
Christoph A. Klein
NATURE REVIEWS CANCER (2009)
Collagen density promotes mammary tumor initiation and progression
Paolo P. Provenzano et al.
BMC MEDICINE (2008)
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Gali Soria et al.
CANCER LETTERS (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis
SE Moody et al.
CANCER CELL (2002)
Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway
RJ Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
